|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 276, Issue 17, 13718-13726, April 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the § Department of Medicine, Division of
Gastroenterology, and the We have identified a novel basic leucine zipper
(bZIP) protein, designated ATF-7, that physically interacts with the
PRL-1 protein-tyrosine phosphatase (PTPase). PRL-1 is a predominantly nuclear, farnesylated PTPase that has been linked to the control of
cellular growth and differentiation. This interaction was initially found using the yeast two-hybrid system. ATF-7 is most closely related
to members of the ATF/CREB family of bZIP proteins, with highest
homology to ATF-4. ATF-7 homodimers can bind specifically to CRE
elements. ATF-7 is expressed in a number of different tissues and is
expressed in association with differentiation in the Caco-2 cell model
of intestinal differentiation. We have confirmed the PRL-1·ATF-7
interaction and mapped the regions of ATF-7 and PRL-1 important
for interaction to ATF-7's bZIP region and PRL-1's phosphatase domain. Finally, we have determined that PRL-1 is able to
dephosphorylate ATF-7 in vitro. Further insight into
ATF-7's precise cellular roles, transcriptional function, and
downstream targets are likely be of importance in understanding the
mechanisms underlying the complex processes of maintenance,
differentiation, and turnover of epithelial tissues.
ATF-7, a Novel bZIP Protein, Interacts with the PRL-1
Protein-tyrosine Phosphatase*
,,,, and Department of Genetics,
University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania 19104-6145
*
This work is supported by National Institutes of Health
Grants R01 DK52216 and R01 DK44237, by University of Pennsylvania NIDDK/National Institutes of Health Center for Molecular Studies in
Digestive and Liver Diseases Grant P30 DK50306, and by the American
Digestive Health Foundation Miles and Shirley Fiterman Award for Basic
Science Research.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Li, W. Li, J. M. Angelastro, L. A. Greene, and D. X. Liu Identification of a Novel DNA Binding Site and a Transcriptional Target for Activating Transcription Factor 5 in C6 Glioma and MCF-7 Breast Cancer Cells Mol. Cancer Res., June 1, 2009; 7(6): 933 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. KNIPPEN, T. LONING, V. MULLER, C. SCHRODER, F. JANICKE, and K. MILDE-LANGOSCH Expression and Prognostic Value of Activating Transcription Factor 2 (ATF2) and its Phosphorylated Form in Mammary Carcinomas Anticancer Res, January 1, 2009; 29(1): 183 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pascual, M. J. Gomez-Lechon, J. V. Castell, and R. Jover ATF5 Is a Highly Abundant Liver-Enriched Transcription Factor that Cooperates with Constitutive Androstane Receptor in the Transactivation of CYP2B6: Implications in Hepatic Stress Responses Drug Metab. Dispos., June 1, 2008; 36(6): 1063 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tommasino, M. Villani, A. Qureshi, J. Henry, C. Luberto, and M. Del Poeta Atf2 Transcription Factor Binds to the APP1 Promoter in Cryptococcus neoformans: Stimulatory Effect of Diacylglycerol Eukaryot. Cell, February 1, 2008; 7(2): 294 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tateyama, K. Horisawa, H. Takashima, E. Miyamoto-Sato, N. Doi, and H. Yanagawa Affinity selection of DNA-binding protein complexes using mRNA display Nucleic Acids Res., February 14, 2006; 34(3): e27 - e27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Stephens, H. Han, V. Gokhale, and D. D. Von Hoff PRL phosphatases as potential molecular targets in cancer Mol. Cancer Ther., November 1, 2005; 4(11): 1653 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Forgacs, S. K. Gupta, J. A. Kerry, and O. J. Semmes The bZIP Transcription Factor ATFx Binds Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax and Represses HTLV-1 Long Terminal Repeat-Mediated Transcription J. Virol., June 1, 2005; 79(11): 6932 - 6939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Moorefield, S. J. Fry, and J. M. Horowitz Sp2 DNA Binding Activity and trans-Activation Are Negatively Regulated in Mammalian Cells J. Biol. Chem., April 2, 2004; 279(14): 13911 - 13924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Angelastro, T. N. Ignatova, V. G. Kukekov, D. A. Steindler, G. B. Stengren, C. Mendelsohn, and L. A. Greene Regulated Expression of ATF5 Is Required for the Progression of Neural Progenitor Cells to Neurons J. Neurosci., June 1, 2003; 23(11): 4590 - 4600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Persengiev, L. R. Devireddy, and M. R. Green Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors Genes & Dev., July 15, 2002; 16(14): 1806 - 1814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Si, Q. Zeng, C. H. Ng, W. Hong, and C. J. Pallen Interaction of Farnesylated PRL-2, a Protein-tyrosine Phosphatase, with the beta -Subunit of Geranylgeranyltransferase II J. Biol. Chem., August 24, 2001; 276(35): 32875 - 32882. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |